![Igor Smolenov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Igor Smolenov currently works at Arcturus Therapeutics Holdings, Inc., as Chief Development Officer from 2023.
Dr. Smolenov also formerly worked at Clover Pharmaceuticals Corp., as Executive Vice President, Moderna, Inc., as Head-Clinical Development, and Seqirus, Inc., as Head-Therapeutic Area.
Dr. Smolenov received his doctorate degree from Volgograd State Medical University.
| Società | Posizione | Inizio |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Corporate Officer/Principal | 01/04/2023 |
| Società | Posizione | Fine |
|---|---|---|
| MODERNA, INC. | Direttore Tecnico/Scientifico/R&S | - |
Seqirus, Inc.
 Seqirus, Inc. BiotechnologyHealth Technology Develops and manufactures vaccines & pharmaceuticals | Corporate Officer/Principal | - |
Clover Pharmaceuticals Corp.
 Clover Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Clover Pharmaceuticals Corp.
Clover Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seqirus, Inc.
Seqirus, Inc. BiotechnologyHealth Technology Develops and manufactures vaccines & pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
